Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

BACKGROUND. Second-line antiretroviral therapy (ART) based on ritonavir-boosted protease inhibitors (bPIs) represents the only available option after first-line failure for the majority of individuals living with human immunodeficiency virus (HIV) worldwide. Maximizing their effectiveness is imperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Collier, Dami, Iwuji, Collins, Derache, Anne, de Oliveira, Tulio, Okesola, Nonhlanhla, Calmy, Alexandra, Dabis, Francois, Pillay, Deenan, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439490/
https://www.ncbi.nlm.nih.gov/pubmed/28329393
http://dx.doi.org/10.1093/cid/cix015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439490/
https://www.ncbi.nlm.nih.gov/pubmed/28329393
http://dx.doi.org/10.1093/cid/cix015

Ejemplares similares